Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herbert E Klei

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Plos One|September 15, 2015
Correction: High Resolution Crystal Structure of Human β-Glucuronidase Reveals Structural Basis of Lysosome TargetingMd Imtaiyaz Hassan, Abdul Waheed, Jeffery H Grubb, et al.
Plos One|November 22, 2013
High resolution crystal structure of human β-glucuronidase reveals structural basis of lysosome targetingMd Imtaiyaz Hassan, Abdul Waheed, Jeffery H Grubb, et al.
Acta Crystallographica. Section D, Biological Crystallography|January 15, 2014
Ligand placement based on prior structures: the guided ligand-replacement methodHerbert E Klei, Nigel W Moriarty, Nathaniel Echols, et al.
Protein Science : a Publication of the Protein Society|September 14, 2017
Interactive comparison and remediation of collections of macromolecular structuresNigel W Moriarty, Dorothee Liebschner, Herbert E Klei, et al.
Journal of Virology|June 1, 2007
X-ray crystal structures of human immunodeficiency virus type 1 protease mutants complexed with atazanavirHerbert E Klei, Kevin Kish, Pin-Fang M Lin, et al.
Acta Crystallographica. Section D, Biological Crystallography|January 15, 2014
Automating crystallographic structure solution and refinement of protein-ligand complexesNathaniel Echols, Nigel W Moriarty, Herbert E Klei, et al.
Protein Science : a Publication of the Protein Society|January 30, 2008
Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formationWilliam J Metzler, Joseph Yanchunas, Carolyn Weigelt, et al.
The Biochemical Journal|March 18, 2011
Structural basis for CARM1 inhibition by indole and pyrazole inhibitorsJohn S Sack, Sandrine Thieffine, Tiziano Bandiera, et al.
Cancer Research|June 3, 2006
The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutantsJohn S Tokarski, John A Newitt, Chieh Ying J Chang, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2011
7-Oxopyrrolopyridine-derived DPP4 inhibitors-mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active siteWei Wang, Pratik Devasthale, Aiying Wang, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Plos One|September 15, 2015
Correction: High Resolution Crystal Structure of Human β-Glucuronidase Reveals Structural Basis of Lysosome TargetingMd Imtaiyaz Hassan, Abdul Waheed, Jeffery H Grubb, et al.
Plos One|November 22, 2013
High resolution crystal structure of human β-glucuronidase reveals structural basis of lysosome targetingMd Imtaiyaz Hassan, Abdul Waheed, Jeffery H Grubb, et al.
Acta Crystallographica. Section D, Biological Crystallography|January 15, 2014
Ligand placement based on prior structures: the guided ligand-replacement methodHerbert E Klei, Nigel W Moriarty, Nathaniel Echols, et al.
Protein Science : a Publication of the Protein Society|September 14, 2017
Interactive comparison and remediation of collections of macromolecular structuresNigel W Moriarty, Dorothee Liebschner, Herbert E Klei, et al.
Journal of Virology|June 1, 2007
X-ray crystal structures of human immunodeficiency virus type 1 protease mutants complexed with atazanavirHerbert E Klei, Kevin Kish, Pin-Fang M Lin, et al.
Acta Crystallographica. Section D, Biological Crystallography|January 15, 2014
Automating crystallographic structure solution and refinement of protein-ligand complexesNathaniel Echols, Nigel W Moriarty, Herbert E Klei, et al.
Protein Science : a Publication of the Protein Society|January 30, 2008
Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formationWilliam J Metzler, Joseph Yanchunas, Carolyn Weigelt, et al.
The Biochemical Journal|March 18, 2011
Structural basis for CARM1 inhibition by indole and pyrazole inhibitorsJohn S Sack, Sandrine Thieffine, Tiziano Bandiera, et al.
Cancer Research|June 3, 2006
The structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutantsJohn S Tokarski, John A Newitt, Chieh Ying J Chang, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2011
7-Oxopyrrolopyridine-derived DPP4 inhibitors-mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active siteWei Wang, Pratik Devasthale, Aiying Wang, et al.
Pageof 3